?? ?Premium-Grade Estradiol Cypionate: Long-Acting Hormone for Pharma & Veterinary Excellence?

?? ?Product Overview?

?Estradiol Cypionate? (CAS 313-06-4), a synthetic estrogen ester, delivers ?3-4 weeks of sustained hormone release? through its unique cyclopentylpropionate structure. As a potent ?ET-1 inhibitor?, it enhances vascular health and reduces oxidative stress, making it ideal for hormone replacement therapy (HRT), contraceptives, and veterinary reproductive management.

?? ?Key Advantages?

?? ?Applications?

1. ?Human Pharmaceuticals?

• ?HRT?: Alleviates menopausal symptoms (hot flashes, osteoporosis).

• ?Contraceptives?: Combined with progestins for monthly injectables.

• 
  

2. ?Veterinary Medicine?

• Regulates estrous cycles in cattle and supports fertility programs.

• Used in feral cat population control via induced estrous behavior.

? ?Quality & Compliance?

• Meets ?USP/EP pharmacopeia standards?.

• Produced in ?GMP-certified facilities? with ISO 9001 audits.

• Validated ET-1 inhibition via in vitro assays.

?? ?Market Insights?

The global HRT market is projected to reach ?$29.7B by 2030?, driven by aging populations. Veterinary hormone demand grows at ?4.3% annually?, with Asia-Pacific leading adoption for livestock and wildlife management.